Screener · short volume
Short volume screener
Screen US-listed companies by FINRA daily short volume. Filter by market cap, sector, and industry, and sort by short %, short volume, total volume, or market cap.
1D · FINRA Reg SHO · as of Apr 24, 2026
| # | Ticker | Company | Sector | Market cap | Short | Total | Short % |
|---|---|---|---|---|---|---|---|
| 1 | HSIC | Henry Schein Inc. | Health CareMedical Specialities | $8.90B | 295.7K | 320.6K | 92.2% |
| 2 | RAPP | Rapport Therapeutics Inc. | Health CareBiotechnology: Pharmaceutical Preparations | $1.75B | 93.1K | 101.9K | 91.3% |
| 3 | BLLN | BillionToOne Inc. | Health CareMedical Specialities | $3.90B | 103.8K | 114.3K | 90.8% |
| 4 | ZLAB | Zai Lab Limited | Health CareBiotechnology: Pharmaceutical Preparations | $2.56B | 156.8K | 175.0K | 89.6% |
| 5 | GMAB | Genmab A/S | Health CareBiotechnology: Pharmaceutical Preparations | $17.26B | 315.9K | 356.5K | 88.6% |
| 6 | ZBIO | Zenas BioPharma Inc. | Health CareBiotechnology: Pharmaceutical Preparations | $1.04B | 206.2K | 234.8K | 87.8% |
| 7 | MANE | Veradermics Incorporated | Health CareBiotechnology: Pharmaceutical Preparations | $2.53B | 143.7K | 167.2K | 86.0% |
| 8 | PHAT | Phathom Pharmaceuticals Inc. | Health CareBiotechnology: Pharmaceutical Preparations | $929.3M | 534.1K | 626.1K | 85.3% |
| 9 | HURA | TuHURA Biosciences Inc. | Health CareBiotechnology: Pharmaceutical Preparations | $149.4M | 275.7K | 325.7K | 84.6% |
| 10 | SIBN | SI-BONE Inc. | Health CareMedical/Dental Instruments | $597.6M | 99.3K | 117.8K | 84.3% |
| 11 | BVS | Bioventus Inc. | Health CareMedical/Dental Instruments | $841.8M | 114.1K | 135.7K | 84.1% |
| 12 | PRKS | United Parks & Resorts Inc. | Health CareBiotechnology: Electromedical & Electrotherapeutic Apparatus | $1.64B | 189.3K | 226.9K | 83.4% |
| 13 | INCY | Incyte Corp. | Health CareBiotechnology: Commercial Physical & Biological Resarch | $18.84B | 314.5K | 377.8K | 83.2% |
| 14 | AKTS | Aktis Oncology Inc. | Health CareBiotechnology: Pharmaceutical Preparations | $1.18B | 92.2K | 111.7K | 82.6% |
| 15 | SOLV | Solventum Corporation | Health CareMedical/Dental Instruments | $11.88B | 146.1K | 177.6K | 82.3% |
| 16 | VTRS | Viatris Inc. | Health CareBiotechnology: Pharmaceutical Preparations | $16.99B | 4.81M | 5.88M | 81.8% |
| 17 | GSK | GSK plc | Health CareBiotechnology: Pharmaceutical Preparations | $111.03B | 1.30M | 1.62M | 80.3% |
| 18 | ENOV | Enovis Corporation | Health CareIndustrial Specialties | $1.38B | 244.2K | 309.8K | 78.8% |
| 19 | KLRA | Kailera Therapeutics Inc. | Health CareBiotechnology: Pharmaceutical Preparations | $2.76B | 432.3K | 550.5K | 78.5% |
| 20 | NNOX | NANO-X IMAGING LTD | Health CareMedical Electronics | $120.7M | 1.68M | 2.14M | 78.5% |
| 21 | ITGR | Integer Holdings Corporation | Health CareBiotechnology: Electromedical & Electrotherapeutic Apparatus | $2.93B | 78.9K | 100.7K | 78.3% |
| 22 | PCRX | Pacira BioSciences Inc. | Health CareBiotechnology: Pharmaceutical Preparations | $992.4M | 190.3K | 243.0K | 78.3% |
| 23 | XNCR | Xencor Inc. | Health CareBiotechnology: Pharmaceutical Preparations | $951.9M | 141.5K | 181.3K | 78.1% |
| 24 | ACHV | Achieve Life Sciences Inc. | Health CareBiotechnology: In Vitro & In Vivo Diagnostic Substances | $214.0M | 211.0K | 272.0K | 77.6% |
| 25 | UFPT | UFP Technologies Inc. | Health CareMedical/Dental Instruments | $1.54B | 80.3K | 104.5K | 76.9% |
| 26 | LENZ | LENZ Therapeutics Inc. | Health CareBiotechnology: Biological Products (No Diagnostic Substances) | $294.1M | 210.2K | 274.8K | 76.5% |
| 27 | COSM | Cosmos Health Inc. | Health CareOther Pharmaceuticals | $19.3M | 398.2K | 521.0K | 76.4% |
| 28 | WRBY | Warby Parker Inc. | Health CareOphthalmic Goods | $2.79B | 512.8K | 671.5K | 76.4% |
| 29 | PGNY | Progyny Inc. | Health CareMisc Health and Biotechnology Services | $1.42B | 395.1K | 522.7K | 75.6% |
| 30 | VCYT | Veracyte Inc. | Health CareMedical Specialities | $2.74B | 113.0K | 149.7K | 75.5% |
| 31 | HRMY | Harmony Biosciences Holdings Inc. | Health CareBiotechnology: Pharmaceutical Preparations | $1.78B | 280.3K | 371.7K | 75.4% |
| 32 | HCSG | Healthcare Services Group Inc. | Health CareHospital/Nursing Management | $1.55B | 191.7K | 255.3K | 75.1% |
| 33 | IMNM | Immunome Inc. | Health CareBiotechnology: Pharmaceutical Preparations | $2.67B | 141.3K | 189.2K | 74.7% |
| 34 | PRCT | PROCEPT BioRobotics Corporation | Health CareMedical/Dental Instruments | $1.39B | 284.2K | 380.7K | 74.7% |
| 35 | AMPH | Amphastar Pharmaceuticals Inc. | Health CareBiotechnology: Pharmaceutical Preparations | $953.5M | 92.4K | 124.0K | 74.5% |
| 36 | CRNX | Crinetics Pharmaceuticals Inc. | Health CareBiotechnology: Pharmaceutical Preparations | $4.01B | 325.4K | 437.2K | 74.4% |
| 37 | EXEL | Exelixis Inc. | Health CareBiotechnology: Biological Products (No Diagnostic Substances) | $11.42B | 578.8K | 780.2K | 74.2% |
| 38 | URGN | UroGen Pharma Ltd. | Health CareBiotechnology: Pharmaceutical Preparations | $1.17B | 172.9K | 233.2K | 74.1% |
| 39 | TNXP | Tonix Pharmaceuticals Holding Corp. | Health CareBiotechnology: Pharmaceutical Preparations | $169.0M | 90.7K | 123.0K | 73.7% |
| 40 | MEDP | Medpace Holdings Inc. | Health CareBiotechnology: Commercial Physical & Biological Resarch | $11.72B | 254.2K | 344.9K | 73.7% |
| 41 | JSPR | Jasper Therapeutics Inc. | Health CareBiotechnology: Biological Products (No Diagnostic Substances) | $23.5M | 226.7K | 308.0K | 73.6% |
| 42 | PRAX | Praxis Precision Medicines Inc. | Health CareBiotechnology: Pharmaceutical Preparations | $9.60B | 95.5K | 129.8K | 73.6% |
| 43 | CMPX | Compass Therapeutics Inc. | Health CareBiotechnology: Biological Products (No Diagnostic Substances) | $905.8M | 1.11M | 1.52M | 73.2% |
| 44 | FOLD | Amicus Therapeutics Inc. | Health CareBiotechnology: Pharmaceutical Preparations | $4.55B | 1.18M | 1.61M | 73.2% |
| 45 | BBNX | Beta Bionics Inc. | Health CareMedical/Dental Instruments | $497.8M | 236.6K | 323.3K | 73.2% |
| 46 | RDNT | RadNet Inc. | Health CareMedical Specialities | $4.53B | 104.4K | 142.8K | 73.1% |
| 47 | DVA | DaVita Inc. | Health CareMisc Health and Biotechnology Services | $10.01B | 165.4K | 226.2K | 73.1% |
| 48 | HALO | Halozyme Therapeutics Inc. | Health CareBiotechnology: Biological Products (No Diagnostic Substances) | $7.74B | 377.7K | 517.4K | 73.0% |
| 49 | UHS | Universal Health Services Inc. | Health CareHospital/Nursing Management | $10.64B | 199.8K | 274.1K | 72.9% |
| 50 | HCA | HCA Healthcare Inc. | Health CareHospital/Nursing Management | $96.68B | 1.17M | 1.60M | 72.9% |
| 51 | LIVN | LivaNova PLC | Health CareBiotechnology: Electromedical & Electrotherapeutic Apparatus | $3.51B | 111.4K | 153.7K | 72.5% |
| 52 | EHAB | Enhabit Inc. | Health CareMedical/Nursing Services | $696.9M | 293.0K | 404.8K | 72.4% |
| 53 | AMGN | Amgen Inc. | Health CareBiotechnology: Biological Products (No Diagnostic Substances) | $185.95B | 545.0K | 755.5K | 72.1% |
| 54 | CORT | Corcept Therapeutics Incorporated | Health CareBiotechnology: Pharmaceutical Preparations | $4.94B | 135.6K | 188.4K | 71.9% |
| 55 | VSTM | Verastem Inc. | Health CareBiotechnology: Pharmaceutical Preparations | $519.2M | 368.4K | 512.5K | 71.9% |
| 56 | NUVL | Nuvalent Inc. | Health CareBiotechnology: Pharmaceutical Preparations | $8.22B | 277.4K | 386.2K | 71.8% |
| 57 | ATEC | Alphatec Holdings Inc. | Health CareMedical/Dental Instruments | $1.65B | 927.1K | 1.29M | 71.8% |
| 58 | NEOG | Neogen Corporation | Health CareBiotechnology: In Vitro & In Vivo Diagnostic Substances | $2.08B | 395.9K | 552.2K | 71.7% |
| 59 | LH | Labcorp Holdings Inc. | Health CareMedical Specialities | $21.68B | 117.4K | 164.0K | 71.6% |
| 60 | UPB | Upstream Bio Inc. | Health CareBiotechnology: Pharmaceutical Preparations | $506.1M | 135.5K | 189.4K | 71.6% |
| 61 | BBOT | BridgeBio Oncology Therapeutics Inc. | Health CareBiotechnology: Pharmaceutical Preparations | $702.7M | 104.3K | 146.5K | 71.2% |
| 62 | GANX | Gain Therapeutics Inc. | Health CareBiotechnology: Pharmaceutical Preparations | $83.2M | 256.0K | 360.4K | 71.0% |
| 63 | INBX | Inhibrx Biosciences Inc. | Health CareBiotechnology: Biological Products (No Diagnostic Substances) | $1.89B | 142.1K | 200.0K | 71.0% |
| 64 | MBX | MBX Biosciences Inc. | Health CareBiotechnology: Pharmaceutical Preparations | $1.52B | 126.7K | 178.6K | 71.0% |
| 65 | RCUS | Arcus Biosciences Inc. | Health CareBiotechnology: Pharmaceutical Preparations | $3.20B | 161.9K | 229.6K | 70.5% |
| 66 | GMED | Globus Medical Inc. | Health CareMedical/Dental Instruments | $12.83B | 166.0K | 235.5K | 70.5% |
| 67 | MLYS | Mineralys Therapeutics Inc. | Health CareBiotechnology: Pharmaceutical Preparations | $2.27B | 149.9K | 213.1K | 70.3% |
| 68 | MIRM | Mirum Pharmaceuticals Inc. | Health CareBiotechnology: Pharmaceutical Preparations | $5.52B | 90.6K | 129.0K | 70.2% |
| 69 | STE | STERIS plc (Ireland) | Health CareIndustrial Specialties | $21.75B | 116.6K | 167.2K | 69.7% |
| 70 | INSP | Inspire Medical Systems Inc. | Health CareMedical/Dental Instruments | $1.62B | 157.1K | 225.6K | 69.6% |
| 71 | IART | Integra LifeSciences Holdings Corporation | Health CareMedical/Dental Instruments | $823.8M | 104.4K | 150.1K | 69.5% |
| 72 | SYRE | Spyre Therapeutics Inc. | Health CareBiotechnology: Pharmaceutical Preparations | $6.46B | 147.1K | 211.9K | 69.4% |
| 73 | OMER | Omeros Corporation | Health CareBiotechnology: Pharmaceutical Preparations | $974.1M | 446.5K | 643.7K | 69.4% |
| 74 | NRIX | Nurix Therapeutics Inc. | Health CareBiotechnology: Pharmaceutical Preparations | $1.72B | 96.3K | 138.9K | 69.4% |
| 75 | TVTX | Travere Therapeutics Inc. | Health CareBiotechnology: Pharmaceutical Preparations | $3.74B | 467.8K | 675.9K | 69.2% |
| 76 | NUVB | Nuvation Bio Inc. | Health CareBiotechnology: Pharmaceutical Preparations | $1.70B | 1.62M | 2.35M | 69.1% |
| 77 | AMLX | Amylyx Pharmaceuticals Inc. | Health CareBiotechnology: Pharmaceutical Preparations | $1.88B | 153.2K | 221.8K | 69.1% |
| 78 | CON | Concentra Group Holdings Parent Inc. | Health CareMedical Specialities | $2.93B | 151.8K | 220.3K | 68.9% |
| 79 | MO | Altria Group Inc. | Health Care Medicinal Chemicals and Botanical Products | $111.78B | 2.50M | 3.62M | 68.9% |
| 80 | ABCL | AbCellera Biologics Inc. | Health CareBiotechnology: Pharmaceutical Preparations | $1.22B | 3.46M | 5.03M | 68.9% |
| 81 | CAI | Caris Life Sciences Inc. | Health CareMedical Specialities | $971.9M | 223.5K | 324.8K | 68.8% |
| 82 | JBIO | Jade Biosciences Inc. | Health CareBiotechnology: Pharmaceutical Preparations | $1.23B | 265.6K | 386.8K | 68.7% |
| 83 | CGEM | Cullinan Therapeutics Inc. | Health CareBiotechnology: Biological Products (No Diagnostic Substances) | $800.2M | 198.6K | 289.6K | 68.6% |
| 84 | RDY | Dr. Reddy's Laboratories Ltd | Health CareBiotechnology: Pharmaceutical Preparations | $11.41B | 594.7K | 867.6K | 68.5% |
| 85 | KOD | Kodiak Sciences Inc | Health CareBiotechnology: Biological Products (No Diagnostic Substances) | $2.79B | 118.2K | 173.5K | 68.2% |
| 86 | CLPT | ClearPoint Neuro Inc. | Health CareMedical/Dental Instruments | $353.2M | 144.5K | 212.8K | 67.9% |
| 87 | ACHC | Acadia Healthcare Company Inc. | Health CareMedical Specialities | $2.52B | 682.3K | 1.01M | 67.8% |
| 88 | BEAM | Beam Therapeutics Inc. | Health CareBiotechnology: Biological Products (No Diagnostic Substances) | $2.79B | 996.9K | 1.47M | 67.8% |
| 89 | GKOS | Glaukos Corporation | Health CareMedical/Dental Instruments | $7.11B | 82.4K | 121.7K | 67.7% |
| 90 | HUMA | Humacyte Inc. | Health CareBiotechnology: Biological Products (No Diagnostic Substances) | $155.4M | 758.2K | 1.12M | 67.6% |
| 91 | MDAI | Spectral AI Inc. | Health CareMedical/Dental Instruments | $58.6M | 106.8K | 158.9K | 67.2% |
| 92 | IMVT | Immunovant Inc. | Health CareBiotechnology: Biological Products (No Diagnostic Substances) | $5.82B | 381.9K | 568.7K | 67.2% |
| 93 | NEO | NeoGenomics Inc. | Health CarePrecision Instruments | $1.08B | 275.4K | 412.0K | 66.8% |
| 94 | CDNA | CareDx Inc. | Health CareMedical Specialities | $1.09B | 115.3K | 172.5K | 66.8% |
| 95 | CRSP | CRISPR Therapeutics AG | Health CareBiotechnology: Biological Products (No Diagnostic Substances) | $4.70B | 982.0K | 1.47M | 66.7% |
| 96 | KYMR | Kymera Therapeutics Inc. | Health CareBiotechnology: Biological Products (No Diagnostic Substances) | $6.93B | 84.5K | 126.9K | 66.5% |
| 97 | EHC | Encompass Health Corporation | Health CareHospital/Nursing Management | $10.14B | 264.3K | 398.5K | 66.3% |
| 98 | TMCI | Treace Medical Concepts Inc. | Health CareMedical/Dental Instruments | $128.3M | 85.7K | 129.3K | 66.3% |
| 99 | BAX | Baxter International Inc. | Health CareMedical/Dental Instruments | $9.35B | 1.18M | 1.79M | 66.2% |
| 100 | GRAL | GRAIL Inc. | Health CareMedical Specialities | $2.23B | 187.5K | 283.4K | 66.1% |